P21 research monograph — the CNTF-derived neurogenic peptide

P21 is a nootropic-category research peptide whose evidence base is entirely
preclinical — the most important fact to establish up front.

Chemical identity & structure.
P21 (also written P021) is a small synthetic peptide derived from a biologically
active region of ciliary neurotrophic factor (CNTF). It was engineered in
academic research to be a small, more drug-like molecule that retains a
neurogenic activity associated with CNTF, with chemical modifications intended to
improve stability and brain penetration.

Mechanism of action.
The mechanism reported in the research literature centers on promoting
neurogenesis — the formation of new neurons — and on supporting neurotrophic
signaling, including effects associated with brain-derived neurotrophic factor
(BDNF). Some research also reports effects on the abnormal protein modifications
implicated in neurodegenerative disease. These mechanisms are reported from
preclinical work and should be read as research findings, not established human
pharmacology.

Key research findings.
Preclinical research — in rodent models, including models of Alzheimer-type
pathology — has reported neurogenic and cognition-related effects. These
preclinical findings are what generated interest in the compound.

The research / citation base.
P21's evidence is preclinical only. There is **no meaningful human clinical
data, and it is not approved** for any use. Its human safety profile is
uncharacterized. Marketing that presents P21 as a proven cognitive enhancer is
far ahead of an evidence base that does not include humans.

Research protocols in the literature.
Animal studies have used injected and other routes. There is no validated human
research protocol.

Quality & sourcing notes.
A batch-specific COA with mass-spectrometry identity and HPLC purity is the
minimum bar. The decisive limitation is the absence of human data, which no COA
can address.

*Research-use note: Educational summary of published research. P21 is a
non-approved compound with no human data; this is research context only and not
medical advice.*